{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:07:36Z","timestamp":1781140056469,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejim.2012.11.010","type":"journal-article","created":{"date-parts":[[2012,12,13]],"date-time":"2012-12-13T00:49:02Z","timestamp":1355359742000},"page":"444-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis"],"prefix":"10.1016","volume":"24","author":[{"given":"E.F.H.","family":"van Bommel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Pelkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.R.","family":"Hendriksz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2012.11.010_bb0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(06)68035-5","article-title":"Retroperitoneal fibrosis","volume":"367","author":"Vaglio","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.11.010_bb0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","article-title":"Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation","volume":"88","author":"Van Bommel","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2012.11.010_bb0015","first-page":"784","article-title":"Retroperitoneal fibrosis revisited","volume":"10","author":"Mitchinson","year":"1986","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejim.2012.11.010_bb0020","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2559.1990.tb01541.x","article-title":"The spectrum of chronic peri-aortitis","volume":"16","author":"Parums","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.ejim.2012.11.010_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)64677-0","article-title":"Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration","volume":"168","author":"Kardar","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0030","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/bjs.1800750625","article-title":"Non-operative management of retroperitoneal fibrosis","volume":"75","author":"Higgins","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejim.2012.11.010_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","article-title":"Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone","volume":"49","author":"Van Bommel","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ejim.2012.11.010_bb0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000119715","article-title":"Successful use of steroids and ureteric stents in 24 patients with idiopathic retroperitoneal fibrosis: a retrospective study","volume":"108","author":"Fry","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ejim.2012.11.010_bb0045","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-410X.2006.06210.x","article-title":"Idiopathic retroperitoneal fibrosis: the case for nonsurgical treatment","volume":"98","author":"Ilie","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.ejim.2012.11.010_bb0050","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1093\/ndt\/gfl228","article-title":"Long-term results of idiopathic retroperitoneal fibrosis treated with surgical and\/or medical approaches","volume":"21","author":"Moroni","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2012.11.010_bb0055","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/00365599409181272","article-title":"Retroperitoneal fibrosis treated with methylprednisolone pulse and disease-modifying drugs","volume":"28","author":"Harreby","year":"1994","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0060","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.amjmed.2003.08.033","article-title":"Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases","volume":"116","author":"Marcolongo","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2012.11.010_bb0065","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2004.029793","article-title":"Immunosuppressive treatment of chronic peri-aortitis: a retrospective study of 20 patients and a review of the literature","volume":"64","author":"Warnatz","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2012.11.010_bb0070","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/rheumatology\/ken291","article-title":"Successful mycophenolatemofetil therapy in nine patients with idiopathic retroperitoneal fibrosis","volume":"47","author":"Adler","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejim.2012.11.010_bb0075","doi-asserted-by":"crossref","first-page":"260","DOI":"10.5414\/CNP69260","article-title":"Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil","volume":"69","author":"Swartz","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.7326\/0003-4819-154-1-201101040-00005","article-title":"Combined prednisone and mycophenolate mofetil treatment for retroperitoneal fibrosis","volume":"154","author":"Scheel","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2012.11.010_bb0085","first-page":"502","article-title":"The response of retroperitoneal fibrosis to tamoxifen","volume":"109","author":"Clark","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2012.11.010_bb0090","article-title":"Tamoxifen for retroperitoneal fibrosis","volume":"382","author":"Loffeld","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.11.010_bb0095","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2214\/ajr.164.2.7840016","article-title":"Treatment of retroperitoneal fibrosis with tamoxifen","volume":"164","author":"Spillane","year":"1995","journal-title":"AJR"},{"key":"10.1016\/j.ejim.2012.11.010_bb0100","first-page":"515","article-title":"Retroperitoneal fibrosis treated with tamoxifen","author":"Owens","year":"1995","journal-title":"Am Surg"},{"key":"10.1016\/j.ejim.2012.11.010_bb0105","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/ndt\/12.11.2407","article-title":"Treatment of idiopathic retroperitoneal fibrosis with tamoxifen","volume":"12","author":"Bourouma","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2012.11.010_bb0110","first-page":"231","article-title":"Treatment of idiopathic retroperitoneal fibrosis by tamoxifen","volume":"163","author":"Tonietto","year":"1997","journal-title":"Eur J Surg"},{"key":"10.1016\/j.ejim.2012.11.010_bb0115","first-page":"578","article-title":"Regression d\u00fane fibrose retroperitoneale traitee par le tamoxifene","volume":"6","author":"Devevey","year":"1996","journal-title":"Prog Urol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/pgmj.73.864.653","article-title":"Tamoxifen for retroperitoneal fibrosis (peri-aneurysmal fibrosis)","volume":"73","author":"Frankart","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2012.11.010_bb0125","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/003655902320783953","article-title":"Clinical and radiological evolution of a case of idiopathic retroperitoneal fibrosis treated with tamoxifen","volume":"36","author":"Al Rabi","year":"2002","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0130","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-410X.1998.00744.x","article-title":"Idiopathic retroperitoneal fibrosis treated with tamoxifen only","volume":"82","author":"Al-Musawi","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0135","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/ndt\/12.10.2166","article-title":"Potential beneficial effect of tamoxifen in retroperitoneal fibrosis","volume":"12","author":"Ozener","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2012.11.010_bb0140","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/00007611-200208000-00038","article-title":"Treatment of retroperitoneal fibrosis with tamoxifen","volume":"95","author":"Al-Salman","year":"2002","journal-title":"South Med J"},{"key":"10.1016\/j.ejim.2012.11.010_bb0145","first-page":"184","article-title":"Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of the literature","volume":"53","author":"Puce","year":"2000","journal-title":"Arch Esp Urol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0150","first-page":"1693","article-title":"Successful treatment of retroperitoneal fibrosis with tamoxifen in a child","volume":"28","author":"Dedeoglu","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0155","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0140-6736(11)60934-3","article-title":"Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomized controlled trial","volume":"378","author":"Vaglio","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.11.010_bb0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/nur.4770130405","article-title":"A critical review of visual analogue scales in the measurement of clinical phenomena","volume":"13","author":"Wewers","year":"1990","journal-title":"Res Nurs Health"},{"key":"10.1016\/j.ejim.2012.11.010_bb0165","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","article-title":"Brief communication: tamoxifen therapy for idiopathic retroperitoneal fibrosis","volume":"144","author":"Van Bommel","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2012.11.010_bb0170","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.CIR.0000154545.84124.AC","article-title":"Effect of tamoxifen on venous thromboembolic events in a breast cancer prevention trial","volume":"111","author":"Decensi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.11.010_bb0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1464-410X.2003.04483.x","article-title":"Auto-allergic periaortitis (idiopathic retroperitoneal fibrosis)","volume":"92","author":"Baker","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.ejim.2012.11.010_bb0180","doi-asserted-by":"crossref","first-page":"764","DOI":"10.7326\/0003-4819-141-10-200411160-00007","article-title":"Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease","volume":"141","author":"Wei","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2012.11.010_bb0185","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/CIRCULATIONAHA.104.531178","article-title":"Tamoxifen for the prevention of myocardial infarction in humans: preclinical and early clinical evidence","volume":"112","author":"Grainger","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2012.11.010_bb0190","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/0140-6736(93)90618-Q","article-title":"Tamoxifen for retroperitoneal fibrosis","volume":"341","author":"Benson","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2012.11.010_bb0195","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/jsre.2001.6350","article-title":"Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia","volume":"103","author":"Kuhn","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.ejim.2012.11.010_bb0200","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00000637-199805000-00008","article-title":"Tamoxifen downregulates TGF-beta production in keloid fibroblasts","volume":"40","author":"Chau","year":"1998","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.ejim.2012.11.010_bb0205","first-page":"8742","article-title":"Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo","volume":"63","author":"Garvin","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejim.2012.11.010_bb0210","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/ejso.2001.1177","article-title":"Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo","volume":"27","author":"McNamara","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0215","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S1567-5769(01)00045-5","article-title":"Estrogen, prolactin and autoimmunity: actions and interactions","volume":"1","author":"McMurray","year":"2001","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ejim.2012.11.010_bb0220","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1191\/0961203304lu1094oa","article-title":"Sex hormones influence on the immune system: basic and clinical aspects of autoimmunity","volume":"13","author":"Cutolo","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.ejim.2012.11.010_bb0225","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1136\/annrheumdis-2011-201166","article-title":"Rituximab therapy for chronic peri-aortitis","volume":"71","author":"Maritati","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ejim.2012.11.010_bb0230","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5414\/CNP70172","article-title":"A paraneoplastic retroperitoneal fibrosis resistant to corticosteroids treated with tamoxifen","volume":"70","author":"Costanzi","year":"2008","journal-title":"Clin Nephrol"},{"issue":"7","key":"10.1016\/j.ejim.2012.11.010_bb0235","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1093\/ndt\/gfr779","article-title":"Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis","volume":"27","author":"Pelkmans","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2012.11.010_bb0240","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.24461","article-title":"Do acute-phase reactants predict response to glucocorticoid therapy in retroperitoneal fibrosis?","volume":"61","author":"Magrey","year":"2009","journal-title":"Arthritis Rheum"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051200297X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095362051200297X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T20:31:27Z","timestamp":1562445087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095362051200297X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S095362051200297X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2012.11.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2012.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}